-
First floor
Riforma della legislazione farmaceutica in UE
L’accesso ai medicinali varia da un paese all’altro in Europa. Alcuni europei devono attendere in media 4 mesi per trovare…
Leggi » -
First floor
Tempistiche e diseguaglianze regionali per l’accesso ai farmaci. Distribuzione: 20 giorni al Nord, un anno al Sud
Pharma Value ha partecipato nella giornata del 3 luglio 2023 con Ginevra Mastroianni che ha presentato un’analisi sulle tempistiche di…
Leggi » -
First floor
Puglia. Fimmg appeal ignored. The junta still cuts pharmaceutical spending
Squeeze on medicines in Puglia, the goal is a saving of almost 8 million Healthcare: new cost containment measures for…
Leggi » -
First floor
Swiss. Will artificial intelligence change the world of medicines?
Faster search and lower costs: companies have been investing in this technology for some time BASEL – Artificial intelligence (AI) could…
Leggi » -
First floor
Device paybacks. The deadline has been postponed to October 31st
The Council of Ministers No. 45 of July 26, on the proposal of the President Giorgia Meloni, the Minister of Economy and Finance…
Leggi » -
News
ISTAT. Pharmaceutical industry turnover in May 2023: +13.0%
Turnover of industry - May 2023 ISTAT press release - 28 July 2023 In May it is estimated that the turnover of industry, at…
Leggi » -
First floor
AIFA. Trend of pharmaceutical expenditure supported by the NHS from 2019 to 2022
The analysis of the trend in pharmaceutical spending supported by the NHS shows an increasing trend in 2022, after a period of substantial…
Leggi » -
First floor
EMA. The review concerning the bioequivalence studies conducted by Synapse Labs Pvt. Ltd (India) has started
Review launched concerning studies conducted by Synapse Labs Pvt. Ltd (India) EMA – 21 July 2023 The European Agency…
Leggi » -
First floor
Guidelines on health advertising of over-the-counter medicines (OTC) and non-prescription medicines (SOP)
The new guidelines on the health advertising of self-medication medicines (OTC) and non-binding medicines have been published…
Leggi » -
News
Pharmaceutical and Biomedical. CGIL and Filctem: Useless catwalk to the Ministry. We need a discussion on industrial policies
Pharmaceutical and biomedical: CGIL and Filctem, useless Mimit bridges, discussion on industrial policies is needed "Up to now we have defined interlocutors ...
Leggi »